Convenzione Ministries – Human Technopole: National Facilities approved
The Consiglio di Sorveglianza of the Human Technopole Foundation has approved the implementation of five National Facilities, intended as infrastructural facilities with a high technological impact, available to the national research community.
As prescribed by the Convenzione stipulated pursuant to Law 160/2019, the approval follows a two-stage public consultation process: the first stage involved representatives of universities, research hospitals, public research organisations, industry, regions, social partners and third sector bodies conducting or funding research in the life sciences. The results collected during the first phase were then shared with the Italian scientific community to collect their comments and opinions.
The National Facilities identified are as follows:
- National Facility for Genomics
- National Facility for Genome Engineering
- National Facility for Structural Biology
- National Facility for Light Imaging
- National Facility for Data Handling & Analysis
The preparation of the call for the expression of interest is currently underway to collect applications from highly qualified scientists, with no affiliation or existing assignments with the HT Foundation, universities, Italian research hospitals and public research bodies, interested in joining the Standing Independent Evaluation Committee (Commissione Indipendente di Valutazione Permanente – CIVP) in charge of evaluating the requests to access to the National Facilities.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.